Candel Therapeutics Stock (NASDAQ: CADL) stock price, news, charts, stock research, profile.
Open | $1.530 |
Close | $1.580 |
Volume / Avg. | 25.297K / 89.547K |
Day Range | 1.530 - 1.610 |
52 Wk Range | 0.660 - 1.950 |
Market Cap | $41.645M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 1.46% |
Days to Cover | 1.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Candel Therapeutics (NASDAQ: CADL) through any online brokerage.
Other companies in Candel Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and Cellectar Biosciences (NASDAQ:CLRB).
The latest price target for Candel Therapeutics (NASDAQ: CADL) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 11.00 expecting CADL to rise to within 12 months (a possible 663.89% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Candel Therapeutics (NASDAQ: CADL) is $1.44 last updated March 27, 2024 at 7:50 AM EDT.
There are no upcoming dividends for Candel Therapeutics.
Candel Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Candel Therapeutics.
Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.